Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery

Clinical trial NCT02654119 · COMPLETED

Trial details

NCT number: NCT02654119
Sponsor: University of Nebraska
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HER2 Positive Breast Carcinoma Stage I Breast Cancer AJCC v7 Stage IA Breast Cancer AJCC v7 Stage IB Breast Cancer AJCC v7 Stage II Breast Cancer AJCC v6 and v7 Stage IIA Breast Cancer AJCC v6 and v7 Stage IIB Breast Cancer AJCC v6 and v7

Start date: 2015-12-11
Primary completion: 2025-12-08
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.